Search / Trial NCT06230783

Speech Pattern Evaluation and Analysis for Knowledge of AD

Launched by UNIVERSITY OF WISCONSIN, MADISON · Jan 19, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Description

Digital technology, including recorded speech, has the capability of providing a wealth of information about early changes to cognition and communication associated with developing Alzheimer's disease pathology, with the potential for highly accessible, yet low-burden measurement. In this project, researchers will recruit a subset of participants from two longitudinal, observational cohort studies enriched for individuals at risk for or living with Alzheimer's disease to record their speech at home with a mobile device, longitudinally. Our interdisciplinary team will then validate digital m...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Must be enrolled in the Wisconsin Alzheimer\'s Disease Research Center (W-ADRC) Clinical Core or IMPACT studies, or in the Wisconsin Registry for Alzheimer\'s Prevention (WRAP)
  • * Cognitively unimpaired or have a diagnosis of Mild Cognitive Impairment (MCI)
  • * Ages 40-80 years
  • * Have provided W-ADRC or WRAP with blood plasma Alzheimer's Disease
  • Exclusion Criteria:
  • * Not actively enrolled in W-ADRC or WRAP
  • * Diagnosis of dementia
  • * Impaired capacity or unwilling to consent
  • * Have not completed a main W-ADRC/WRAP study visit within approximately 6 months of enrollment
  • * Major neurological conditions
  • * Speech disorders

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Madison, Wisconsin, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0